Silver Book Fact

In the U.S., new cancer drugs have increased life expectancy at birth by 10.7%.

The Expanding Pharmaceutical Arsenal in the War on Cancer. Working Paper No. 10328 Web site. http://www.nber.org/papers/w10328. Published Feb. 2004

Reference

Title
The Expanding Pharmaceutical Arsenal in the War on Cancer
Publication
Working Paper No. 10328
Publisher
National Bureau of Economic Research
Publication Date
Published Feb. 2004
Authors
Lichtenberg, Frank R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Widespread use of telomerase inhibitors could result in a 50% cure rate and a 25% prolongation of life for 50% of eligible patients with solid tumors.  
  • According to the Pharmaceutical Research and Manufacturers of America, a radiopharmaceutical currently in development is a synthetic version of a substance derived from scorpions–chlorotoxin. This could be a powerful…  
  • The use of imatinib (Gleevec) has increased the eight-year survival rate for early chronic-phase myelogenous leukemia from 65% to 84%.  
  • Five-year Relative Survival (%) during Three Time Periods by Cancer Site  
  • There are 3 million more cancer survivors today than there were a decade ago.